37
Participants
Start Date
April 30, 2012
Primary Completion Date
November 30, 2014
Study Completion Date
November 30, 2014
ROSE
The procedure will proceed with conventional EBUS-TBNA sampling of the target lesion with 22 gauge Vizishot needles. Each subject will be randomized to either ROSE by cytopathologist or no ROSE.
22 gauge Vizishot needles
Duke University Medical Center, Durham
Lead Sponsor
Duke University
OTHER